Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism
-
Published:2006-12
Issue:4
Volume:31
Page:277-283
-
ISSN:0378-7966
-
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
-
language:en
-
Short-container-title:European Journal of Drug Metabolism and Pharmacokinetics
Author:
Wu Wu-Nan,Mckown Linda A.,Reitz Allen B.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference15 articles.
1. Maryanoff, B.E., McComsey, D.F., and Ho, W. ( 1993): 3-Oxopyrido[ 1,2- A]benzimidazole-4-carboxyl and4-oxoazepine [l,2-A]benzimidazole-5-carboxyl derivatives useful for treating central system disorders, US Patent 5,639,760 2. Maryanoff, B.E., Ho, W., McComsey, D.F., Reitz, A.B.. Grous, P.P., Nortey, S.O., Shank, R.P., Dubinsky, B., Taylor, Jr., R.J., and Gardocki, J.F. (1995): Potential anxiolytic agents, pyrido[l,2-o]benzimidazole: a new structural class of ligands for the benzodiazepine binding site on GABA-A receptors, J. Med. Chem., 38, 16–20. 3. Maryanoff, B.E., McComsey, D.F., Ho, W., Shank, R.P., and Dubinsky, B. (1996): Potential anxiolytic agents — II. Improvement of oral efficacy for the pyrido[ 1,2-α]benzimidazole (PBI) class of GABA-A receptor moderators, Bioorg. Med. Chem Lett., 6, 333–338. 4. Maryanoff, B.E., Nortey, S.O., McNally, J.J., Sanfilippo, P.J., McComsey, D.F., Dubinsky, B., Shank, R.P., and Reitz, A.B. (1999): Potential anxiolytic agents: 3. novel A-ring modified pyrido[1,2-α]benzimidazole, Bioorg. Med. Chem. Lett., 9, 1547–1552. 5. Reitz, A.B., Jordan, A.D., Sanfilippo, P.J., and Vaouyios-Smith, A. (1998): US Patent, 5,817,668,6.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|